Cite
HARVARD Citation
Griffin, P. et al. (n.d.). Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double‐induction chemotherapy: Analysis from a large, single institution experience. American journal of hematology. 92 (3), pp. 232-237. [Online].